![Douglas Calder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 18 748 $ al 30/09/2026
Mr. Douglas W.
Calder is an Independent Director at Lunai Bioworks, Inc., an Independent Director at Zevra Therapeutics, Inc. and a Member at Society For Natural Immunity.
He is on the Board of Directors at Lunai Bioworks, Inc., Zevra Therapeutics, Inc., Nextgennk and BioFlorida, Inc. Mr. Calder was previously employed as a President & Director by Vycellix, Inc., a Director-Investor Relations & Public Relations by Accentia Biopharmaceuticals, Inc., a VP-Strategic Planning & Capital Markets by BioVest International, Inc., a Portfolio Manager by Dean Witter Reynolds, Inc., a Portfolio Manager by Gruntal & Co. LLC, an Executive Vice President by Pulse Evolution Corp., and a President by VyGen-Bio, Inc. He received his undergraduate degree from Florida State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0,25 % | 13/10/2026 | 12.754 ( 0,25 % ) | 18 748 $ | 30/09/2026 |
| 04/06/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director/Miembro de la Junta | 25/04/2023 |
Nextgennk | Director/Miembro de la Junta | 01/06/2019 |
BioFlorida, Inc.
 BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Director/Miembro de la Junta | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| LUNAI BIOWORKS INC. | Director/Miembro de la Junta | 22/10/2026 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Contacto de Relaciones con Inversores | 16/07/2013 |
| ACCENTIA BIOPHARMACEUTICALS INC | Contacto de Relaciones con Inversores | 04/03/2013 |
Dean Witter Reynolds, Inc.
 Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Corporate Officer/Principal | - |
Gruntal & Co. LLC
 Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
Zevra Therapeutics, Inc.
 Zevra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets proprietary prodrugs | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Pulse Evolution Corp.
 Pulse Evolution Corp. Information Technology ServicesTechnology Services Produces photorealistic digital humans and provides digital production | Technology Services |
Dean Witter Reynolds, Inc.
Dean Witter Reynolds, Inc. Investment ManagersFinance Investment management | Finance |
Gruntal & Co. LLC
Gruntal & Co. LLC General GovernmentGovernment Provides financial services | Government |
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
Vycellix, Inc.
 Vycellix, Inc. BiotechnologyHealth Technology Engages in the development of transformational platform technologies for cell & gene-based therapies | Health Technology |
Nextgennk | |
VyGen-Bio, Inc.
 VyGen-Bio, Inc. BiotechnologyHealth Technology Develops cell & gene therapies and treatments for cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
